Neoadjuvant chemoradiation in patients with pancreatic adenocarcinoma

HPB

Volumn 8, Issue 1, 2006, Pages 22-28

  Krempien, Robert ^a   Muenter, M W ^a   Harms, W ^a   Debus, J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CETUXIMAB; CISPLATIN; CYTOTOXIC AGENT; ERLOTINIB; FLUOROURACIL; GEMCITABINE; MITOMYCIN C; PLATELET DERIVED GROWTH FACTOR RECEPTOR INHIBITOR; RECEPTOR BLOCKING AGENT; STREPTOZOCIN; TEGAFUR; UNCLASSIFIED DRUG; VASCULOTROPIN INHIBITOR;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; DISSEMINATED CANCER; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTRAOPERATIVE RADIOTHERAPY; LAPAROTOMY; METASTASIS; MULTIMODALITY CANCER THERAPY; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PERITONEUM METASTASIS; PREOPERATIVE CARE; REVIEW; SURVIVAL RATE; SURVIVAL TIME;

EID: 33745085303     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820500468034     Document Type: Review

References (55)

1. Parkin, DM and Bray, FI and Devesa, SS. (2001) Cancer burden in the year 2000. The global picture Eur J Cancer, 37, pp. S4-S66.
2. Jemal, A and Murray, T and Ward, E and Samuels, A and Tiwari, RC and Ghafoor, A and et al. (2005) Cancer statistics, 2005 CA Cancer J Clin, 55, pp. 10-30
3. Wagner, M and Redaelli, C and Lietz, M and Seiler, CA and Friess, H and Buchler, MW. (2004) Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma Br J Surg, 91, pp. 586-94.
4. Stocken, DD and Buchler, MW and Dervenis, C and Bassi, C and Jeekel, H and Klinkenbijl, JH and et al. (2005) Pancreatic Cancer Meta-analysis Group. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer Br J Cancer, 92, pp. 1372-81.
5. Beger, HG and Rau, B and Gansauge, F and Poch, B and Link, KH. (2003) Treatment of pancreatic cancer: Challenge of the facts World J Surg, 27, pp. 1075-84.
6. Tsai, JY and Iannitti, DA and Safran, H. (2003) Combined modality therapy for pancreatic cancer Semin Oncol, 30(Suppl 9), pp. 71-9.
7. Klinkenbijl, JH and Jeekel, J and Sahmoud, T and van Pel, R and Couvreur, ML and Veenhof, CH and et al. (1999) Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group Ann Surg, 230, pp. 776-82.
8. Neoptolemos, JP and Stocken, DD and Friess, H and Bassi, C and Dunn, JA and Hickey, H and et al. (2004) European Study Group for Pancreatic Cancer. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med, 350, pp. 1200-10.
9. Beger, HG and Poch, B and Schwarz, M and Ganzauge, F. (2003) Pancreatic cancer: The relative importance of neoadjuvant therapy Chirurg, 74, pp. 202-7.
10. Smeenk, HG and Tran, TC and Erdmann, J and van Eijck, CH and Jeekel, J. (2005) Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist? Langenbecks Arch Surg, 390, pp. 94-103.
11. Pedrazzoli, S and DiCarlo, V and Dionigi, R and Mosca, F and Pederzoli, P and Pasquali, C and et al. (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study. Lymphadenectomy Study Group Ann Surg, 228, pp. 508-17.
12. Yeo, CJ and Cameron, JL and Lillemoe, KD and Sohn, TA and Campbell, KA and Sauter, PK and et al. (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: Randomized controlled trial evaluating survival, morbidity, and mortality Ann Surg, 236, pp. 355-66.
13. Demeure, MJ and Doffek, KM and Komorowski, RA and Wilson, SD. (1998) Adenocarcinoma of the pancreas: Detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay Cancer, 83, pp. 1328-34.
14. Hermanek, P. (1998) Pathology and biology of pancreatic ductal adenocarcinoma Langenbecks Arch Surg, 383, pp. 116-20.
15. Kayahara, M and Nagakawa, T and Futagami, F and Kitagawa, H and Ohta, T and Miyazaki, I. (1996) Lymphatic flow and neural plexus invasion associated with carcinoma of the body and tail of the pancreas Cancer, 78, pp. 2485-91.
16. Juhl, H and Kalthoff, H and Kruger, U and Schott, A and Schreiber, HW and Henne-Bruns, D and et al. (1994) Immunocytologic detection of disseminated tumor cells in the peritoneal cavity and bone marrow in patients with pancreatic carcinoma Chirurg, 65, pp. 1111-15.
17. Inoue, S and Tezel, E and Nakao, A. (2001) Molecular diagnosis of pancreatic cancer Hepatogastroenterology, 48, pp. 933-938
18. Kalser, MH and Ellenberg, SS. (1985) Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Arch Surg, 120, pp. 899-903.
19. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987;59:2006-10.
20. Spitz, FR and Abbruzzese, JL and Lee, JE and Pisters, PW and Lowy, AM and Fenoglio, CJ and et al. (1997) Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas J Clin Oncol, 15, pp. 928-37.
21. Fogelman, DR and Chen, J and Chabot, JA and Allendorf, JD and Schrope, BA and Ennis, RD and et al. (2004) The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTX Surg Oncol Clin North Am, 13, pp. 711-35.
22. Chandler, NM and Canete, JJ and Stuart, KE and Callery, MP. (2003) Preoperative chemoradiation in resectable pancreatic cancer J Hepatobilary Pancreat Surg, 10, pp. 61-6.
23. Ishikawa, O and Ohigashi, H and Imaoka, S and Sasaki, Y and Iwanaga, T and Matayoshi, Y and et al. (1994) Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head? Arch Surg, 129, pp. 1075-80.
24. Evans, DB and Rich, TA and Byrd, DR and Cleary, KR and Connelly, JH and Levin, B and et al. (1992) Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas Arch Surg, 127, pp. 1335-9.
25. Hoffman, JP and Weese, JL and Solin, LJ and Engstrom, P and Agarwal, P and Barber, LW and et al. (1995) A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas Am J Surg, 169, pp. 71-7.
26. Hoffman, JP and Lipsitz, S and Pisansky, T and Weese, JL and Solin, L and Benson, AB, 3rd. (1998) Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group Study J Clin Oncol, 16, pp. 317-323.
27. Snady, H and Bruckner, H and Cooperman, A and Paradiso, J and Kiefer, L. (2000) Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial Cancer, 89, pp. 314-27.
28. Mehta, VK and Fisher, G and Ford, JA and Poen, JC and Vierra, MA and Oberhelman, H and et al. (2001) Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas J Gastrointest Surg, 5, pp. 27-35.
29. Pisters, PW and Abbruzzese, JL and Janjan, NA and Cleary, KR and Charnsangavej, C and Goswitz, MS and et al. (1998) Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma J Clin Oncol, 16, pp. 3843-50.
30. Wolff, RA and Evans, DB and Gravel, DM and Lenzi, R and Pisters, PW and Lee, JE and et al. (2001) Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma Clin Cancer Res, 7, pp. 2246-53.
31. Joensuu, TK and Kiviluoto, T and Karkkainen, P and Vento, P and Kivisaari, L and Tenhunen, M and et al. (2004) Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys, 60, pp. 444-52.
32. Calvo, FA and Matute, R and Garcia-Sabrido, JL and Gomez-Espi, M and Martinez, NE and Lozano, MA and et al. (2004) Neoadjuvant chemoradiation with tegafur in cancer of the pancreas: Initial analysis of clinical tolerance and outcome Am J Clin Oncol, 27, pp. 343-9.
33. Coia, L and Hoffman, J and Scher, R and Weese, J and Solin, L and Weiner, L and et al. (1994) Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum Int J Radiat Oncol Biol Phys, 30, pp. 161-7.
34. White, RR and Hurwitz, HI and Morse, MA and Lee, C and Anscher, MS and Paulson, EK and et al. (2001) Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas Ann Surg Oncol, 8, pp. 758-65.
35. Wanebo, HJ and Glicksman, AS and Vezeridis, MP and Clark, J and Tibbetts, L and Koness, RJ and et al. (2000) Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer Arch Surg, 135, pp. 81-7.
36. Wilkowski, R and Thoma, M and Heinemann, V and Rau, HG and Wagner, A and Stoffregen, C and et al. (2003) Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer - feasible and effective Strahlenther Onkol, 179, pp. 78-86.
37. Gunderson, LL and Haddock, MG and Burch, P and Nagorney, D and Foo, ML and Todoroki, T. (1999) Future role of radiotherapy as a component of treatment in biliopancreatic cancers Ann Oncol, 10(Suppl 4), pp. 291-5.
38. Willett, CG and Czito, BG and Bendell, JC and Ryan, DP. (2005) Locally advanced pancreatic cancer J Clin Oncol, 23, pp. 4538-44.
39. Sohn, TA and Lillemoe, KD and Cameron, JL and Pitt, HA and Huang, JJ and Hruban, RH and et al. (1999) Reexploration for periampullary carcinoma: resectability, perioperative results, pathology, and long-term outcome Ann Surg, 229, pp. 393-400.
40. Crane, CH and Beddar, AS and Evans, DB. (2003) The role of intraoperative radiotherapy in pancreatic cancer Surg Oncol Clin North Am, 12, pp. 965-77.
41. Kinsella, TJ and Sindelar, WF. (1996) Intraoperative radiotherapy for pancreatic carcinoma. Experimental and clinical studies Cancer, 78(3S), pp. 598-604.
42. Landry, JC and Yang, GY and Ting, JY and Staley, CA and Torres, W and Esiashvili, N and et al. (2002) Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): Employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity Med Dosim, 27, pp. 121-9.
43. Garcea, G and Neal, CP and Pattenden, CJ and Steward, WP and Berry, DP. (2005) Molecular prognostic markers in pancreatic cancer: A systematic review Eur J Cancer, 41, pp. 2213-36.
44. Segara, D and Biankin, AV and Kench, JG and Langusch, CC and Dawson, AC and Skalicky, DA and et al. (2005) Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia Clin Cancer Res, 11, pp. 3587-96.
45. Awada, A and Mano, M and Mano, M and Hendlisz, A and Piccart, M and (2004) New anticancer agents and therapeutic strategies in development for solid cancers: A clinical perspective Expert Rev Anticancer Ther, 4, pp. 53-60.
46. Xiong, HQ. (2004) Molecular targeting therapy for pancreatic cancer Cancer Chemother Pharmacol, 54(Suppl 1), pp. S69-S77.
47. Willett, CG and Clark, JW. (2003) Update on combined-modality treatment options for pancreatic cancer Oncology (Williston Park), 17(12 Suppl 13), pp. 29-36.
48. Lawrence, TS. (2003) Radiation sensitizers and targeted therapies Oncology (Williston Park), 17(12 Suppl 13), pp. 23-28.
49. Baumann, M and Krause, M. (2004) Targeting the epidermal growth factor receptor in radiotherapy: Radiobiological mechanisms, preclinical and clinical results Radiother Oncol, 72, pp. 257-66.
50. Xiong, HQ and Abbruzzese, JL. (2002) Epidermal growth factor receptor-targeted therapy for pancreatic cancer Semin Oncol, 29(5 Suppl 14), pp. 31-7.
51. Xiong, HQ and Rosenberg, A and LoBuglio, A and Schmidt, W and Wolff, RA and Deutsch, J and et al. (2004) Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: A multicenter phase II Trial J Clin Oncol, 22, pp. 2610-16.
52. Moore, MJ and Goldstein, D and Hamm, J and Figer, A and Hecht, J and Gallinger, S and et al. (2005) Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer. A phase III trial of the National Cancer Institute of Canada Clinical Trials Group [NCIC-CTG] ASCO Meeting Abstracts, 23, pp. 1.
53. Staley, CA and Lee, JE and Cleary, KR and Abbruzzese, JL and Fenoglio, CJ and Rich, TA and et al. (1996) Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head Am J Surg, 171, pp. 118-24.
54. Magnin, V and Moutardier, V and Giovannini, MH and Lelong, B and Giovannini, M and Viret, F and (2003) Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer Int J Radiat Oncol Biol Phys, 55, pp. 1300-4.
55. Aristu, J and Canon, R and Pardo, F and Martinez-Monge, R and Martin-Algarra, S and Manuel Ordonez, J and et al. (2003) Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer Am J Clin Oncol, 26, pp. 30-6.